⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL219313 | 0.48 | — | — | |
| SCHEMBL28900303 | 0.41 | — | — | |
| Water SCHEMBL28768410 | 0.32 | — | — | |
| Water SCHEMBL1954367 | 0.32 | — | — | |
| SCHEMBL28861870 | 0.32 | — | — | |
| Water SCHEMBL10747940 | 0.32 | — | — | |
| Water SCHEMBL31656559 | 0.32 | — | — | |
| Water SCHEMBL3091704 | 0.32 | — | — | |
| Water SCHEMBL22806512 | 0.32 | — | — | |
| Water SCHEMBL8618181 | 0.32 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6783 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250120971-A1 | NOVEL DRUG TREATMENT OF COGNITIVE IMPAIRMENTS ASSOCIATED WITH SCHIZOPHRENIA | FLORIDA ATLANTIC UNIV BOARD OF TRUSTEES (US) | 2025-04-17 | — | — | US | claimed |
| US-20250075265-A1 | ENHANCEMENT OF NUCLEIC ACID POLYMERIZATION BY AROMATIC COMPOUNDS | ROCHE SEQUENCING SOLUTIONS INC (US) | 2025-03-06 | — | — | US | claimed |
| US-20250075147-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NEW FLAVOR AND FRAGRANCE INGREDIENTS | OSMO LABS, PBC | 2025-03-06 | — | — | US | claimed |
| US-20250057962-A1 | PROCESSABLE COMPOSITIONS AND USE FOR THE SAME | RIPPLE THERAPEUTICS CORPORATION (CA) | 2025-02-20 | — | — | US | claimed |
| US-20250011293-A1 | LEUKOTRIENE SYNTHESIS INHIBITORS | NAEGIS PHARMACEUTICALS INC. (CA) | 2025-01-09 | — | — | US | claimed |
| EP-4426712-A1 | PROCESSABLE COMPOSITIONS AND USE FOR THE SAME | Ripple Therapeutics Corporation (CA) | 2024-09-11 | — | — | EP | claimed |
| US-12071404-B2 | Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides | UCB PHARMA GMBH (DE) | 2024-08-27 | — | — | US | claimed |
| US-11970489-B1 | 4-[(substituted 1H-benzimidazol-2-ylsulfanyl)methyl]-6-substituted-2H-chromen-2-ones as larvicidal agents | King Faisal University (SA) | 2024-04-30 | — | — | US | claimed |
| US-11970731-B2 | Enhancement of nucleic acid polymerization by aromatic compounds | Roche Sequencing Solutions, Inc. (US) | 2024-04-30 | — | — | US | claimed |
| EP-4347040-A1 | ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF CANCER | Petra Pharma Corporation (US) | 2024-04-10 | — | — | EP | claimed |
| CN-102690241-A | Benzoyl urea compound containing isoxazoline and isoxazole structure, and preparation and application thereof | UNIV NANKAI | 2012-09-26 | — | — | CN | claimed |
| EP-2350066-A1 | 2,5-DISUBSTITUTED PIPERIDINE OREXIN RECEPTOR ANTAGONISTS | Merck Sharp & Dohme Corp. (US) | 2011-08-03 | — | — | EP | claimed |
| JP-4675427-B2 | — | — | 2011-04-20 | — | — | JP | claimed |
| WO-2010048010-A1 | 2,5-DISUBSTITUTED PIPERIDINE OREXIN RECEPTOR ANTAGONISTS | MERCK SHARP & DOHME CORP. (US) | 2010-04-29 | — | — | WO | claimed |
| EP-2089382-A1 | SUBSTITUTED DIAZEPAN COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS | Merck & Co., Inc. (US) | 2009-08-19 | — | — | EP | claimed |
| WO-2008069997-A1 | SUBSTITUTED DIAZEPAN COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS | MERCK & CO., INC. (US) | 2008-06-12 | — | — | WO | claimed |
| CN-1226993-C | Brightness increasing agent used as whiteness increasing agent | OREAL (FR) | 2005-11-16 | — | — | CN | claimed |
| CN-1654464-A | N,N'-disubstituted dihydrazides compound and its preparing process and application thereof | UNIV NANKAI (CN) | 2005-08-17 | — | — | CN | claimed |
| EP-1200398-A1 | 3-ARYLSULFONYL-2-(SUBSTITUTED METHYL)PROPANOIC ACID DERIVATES AS MATRIX METALLOPROTEINASE INHIBITORS | Pharmacia Italia S.p.A. (IT) | 2002-05-02 | — | — | EP | claimed |
| WO-2001005756-A1 | 3-ARYLSULFONYL-2-(SUBSTITUTED METHYL)PROPANOIC ACID DERIVATES AS MATRIX METALLOPROTEINASE INHIBITORS | PHARMACIA & UPJOHN SPA (IT) | 2001-01-25 | — | — | WO | claimed |